Skip to content

Many HIV-positive patients in London risking their health by use of alternative therapies

Needle-free mode of T-20 dosing looks highly satisfactory for patients

SMART study - treatment breaks lower quality of life

Alphabet of prevention technologies expanding, but no 'magical solution'

Extensively drug-resistant TB rapidly fatal in South Africa

HIV/HCV coinfected patients more prone to end-stage liver disease without treatment

Kaletra monotherapy as effective as triple therapy for at least 18 months

New data shed light on poor outcome in SMART study

Oral solution of tipranavir/ritonavir shows promise for treatment-experienced kids